Header Logo

Connection

Constance Weisner to Depressive Disorder

This is a "connection" page, showing publications Constance Weisner has written about Depressive Disorder.
Connection Strength

1.401
  1. Advising depression patients to reduce alcohol and drug use: factors associated with provider intervention in outpatient psychiatry. Am J Addict. 2014 Nov-Dec; 23(6):570-5.
    View in: PubMed
    Score: 0.410
  2. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76.
    View in: PubMed
    Score: 0.297
  3. Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018 12 01; 241:8-14.
    View in: PubMed
    Score: 0.134
  4. Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord. 2017 Apr 15; 213:168-171.
    View in: PubMed
    Score: 0.122
  5. Point Prevalence of Co-Occurring Behavioral Health Conditions and Associated Chronic Disease Burden Among Adolescents. J Am Acad Child Adolesc Psychiatry. 2016 05; 55(5):408-14.
    View in: PubMed
    Score: 0.114
  6. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7.
    View in: PubMed
    Score: 0.089
  7. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 Nov-Dec; 31(6):564-70.
    View in: PubMed
    Score: 0.072
  8. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007 Sep 06; 90(1):72-80.
    View in: PubMed
    Score: 0.061
  9. Virtual Collaborative Care Versus Specialty Psychiatry Treatment for Depression or Anxiety. J Clin Psychiatry. 2024 Sep 04; 85(3).
    View in: PubMed
    Score: 0.051
  10. Family environment factors and substance abuse severity in an HMO adolescent treatment population. Clin Pediatr (Phila). 2004 May; 43(4):323-33.
    View in: PubMed
    Score: 0.050

© 2024 Kaiser Permanente